NEW YORK (Reuters Health) - Rifabutin-based triple therapy can eradicate Helicobacter pylori even in the face of resistance to clarithromycin or metronidazole, the ERADICATE Hp2 trial shows. "In the U ...

A new therapy to eradicate Helicobacter pylori was effective in half of asymptomatic children tested, according to two reports in the Journal of Pediatric Gastroenterology & Nutrition. Researchers ...

Increasing H pylori antibiotic resistance rates are affecting the efficacy of many traditional treatment options. 3-5 Therefore, alternative treatment options are being explored. To facilitate this ...

The FDA approved two vonoprazan-based regimens, one with amoxicillin and clarithromycin (Voquezna Triple Pak), and one with amoxicillin (Voquezna Dual Pak), to treat Helicobacter pylori (H. pylori) ...

Talicia ® is the first and only FDA approved rifabutin-based H. pylori therapy and is designed to address the high and growing bacterial resistance and diminished efficacy of clarithromycin-based ...

Background and Aims: The adjuvant effects of probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori (H. pylori) infection have not been evaluated. Methods: A total of 337 ...

A new review published in the Cochrane Library, indicates that eradicating Helicobacter pylori bacterium-- the main cause of stomach ulcers - with a short course of therapy comprising two commonly ...

It has been difficult to study the long-term effects of H pylori eradication alone on platelet response, as patients are usually on other treatments as well. In a new study from Korea, ITP patients in ...

The first option for improving the results of first-line H. pylori therapy is to improve the efficacy of triple therapy by increasing treatment duration and/or the dose of PPI. Additional ...

The management of Helicobacter pylori (H. pylori), a globally prevalent gastric pathogen, has long been centered on its eradication to prevent peptic ulcers, gastric malignancies, and related ...